Skip to main content

Regulatory Affairs in the Pharmaceutical Industry

  • 1st Edition - November 14, 2021
  • Editors: Javed Ali, Sanjula Baboota
  • Language: English
  • Paperback ISBN:
    9 7 8 - 0 - 1 2 - 8 2 2 2 1 1 - 9
  • eBook ISBN:
    9 7 8 - 0 - 1 2 - 8 2 2 2 2 3 - 2

Regulatory Affairs in the Pharmaceutical Industry is a comprehensive reference that compiles all the information available pertaining to regulatory procedures currently followed… Read more

Regulatory Affairs in the Pharmaceutical Industry

Purchase options

Limited Offer

Save 50% on book bundles

Immediately download your ebook while waiting for your print delivery. No promo code is needed.

Book bundle cover eBook and print

Institutional subscription on ScienceDirect

Request a sales quote

Regulatory Affairs in the Pharmaceutical Industry is a comprehensive reference that compiles all the information available pertaining to regulatory procedures currently followed by the pharmaceutical industry. Designed to impart advanced knowledge and skills required to learn the various concepts of regulatory affairs, the content covers new drugs, generic drugs and their development, regulatory filings in different countries, different phases of clinical trials, and the submission of regulatory documents like IND (Investigational New Drug), NDA (New Drug Application) and ANDA (Abbreviated New Drug Application).

Chapters cover documentation in the pharmaceutical industry, generic drug development, code of Federal Regulation (CFR), the ANDA regulatory approval process, the process and documentation for US registration of foreign drugs, the regulation of combination products and medical devices, the CTD and ECTD formats, and much more.